Health partnership supports gut health push in Blue Mountains
Australian biotech company Clinical Genomics teamed up with regional insurer, Westfund Health in 2014 to pilot the first commercially available DNA blood that screens for bowel cancer. The new blood test was the result of over a decade of collaborative research between Clinical Genomics, the CSIRO and the Flinders Centre for Innovation in Cancer in Adelaide.
The Blue Mountains played host to the pilot project between July and November 2014. Palin Communications helped coordinate the PR strategy around the roll out and promotion of the pilot.
It saw Lithgow GPs come together for an education that explained the science behind the new test and the logistics for the pilot. Westfund Health provided reimbursements for the either the stool test or the new blood test to members from the Blue Mountains aged 50 or over.